ES2056415T3 - Utilizacion de un derivado de la trimetil-1,3,7 xantina para la obtencion de medicamentos destinados al tratamiento de los trastornos de la memoria y de la enfermedad de alzheimer. - Google Patents

Utilizacion de un derivado de la trimetil-1,3,7 xantina para la obtencion de medicamentos destinados al tratamiento de los trastornos de la memoria y de la enfermedad de alzheimer.

Info

Publication number
ES2056415T3
ES2056415T3 ES90402558T ES90402558T ES2056415T3 ES 2056415 T3 ES2056415 T3 ES 2056415T3 ES 90402558 T ES90402558 T ES 90402558T ES 90402558 T ES90402558 T ES 90402558T ES 2056415 T3 ES2056415 T3 ES 2056415T3
Authority
ES
Spain
Prior art keywords
treatment
obtaining
xantina
trimetil
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90402558T
Other languages
English (en)
Inventor
Annie Kamoun
Elisabeth Mocaer
Gilbert Regnier
Claude Guillonneau
Jacques Duhault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2056415T3 publication Critical patent/ES2056415T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UTILIZACION PARA OBTENER MEDICAMENTOS DESTINADOS AL TRATAMIENTO DE TRASTORNOS DE LA MEMORIA, DE TRASTORNOS INTELECTUALES DE LA SENESCENCIA Y DE LA ENFERMEDAD DE ALZHEIMER, DE LA TRIMETIL-1, 3, 7(DIETILAMINOCARBONIL-4 PIPERAZINO-3 PROPIL)-8 XANTINA, Y DE SALES DE ADICION ACIDA FISIOLOGICAMENTE TOLERABLES.
ES90402558T 1990-08-10 1990-09-17 Utilizacion de un derivado de la trimetil-1,3,7 xantina para la obtencion de medicamentos destinados al tratamiento de los trastornos de la memoria y de la enfermedad de alzheimer. Expired - Lifetime ES2056415T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9010235A FR2665636B1 (fr) 1990-08-10 1990-08-10 Utilisation d'un derive de la trimethyl-1,3,7 xanthine pour le traitement des troubles de la memoire, des troubles intellectuels de la senescence et de la maladie d'alzheimer.

Publications (1)

Publication Number Publication Date
ES2056415T3 true ES2056415T3 (es) 1994-10-01

Family

ID=9399600

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90402558T Expired - Lifetime ES2056415T3 (es) 1990-08-10 1990-09-17 Utilizacion de un derivado de la trimetil-1,3,7 xantina para la obtencion de medicamentos destinados al tratamiento de los trastornos de la memoria y de la enfermedad de alzheimer.

Country Status (15)

Country Link
US (1) US5173491A (es)
EP (1) EP0470317B1 (es)
JP (1) JPH0647539B2 (es)
AT (1) ATE105478T1 (es)
AU (1) AU631679B2 (es)
CA (1) CA2026118C (es)
DE (1) DE69008853T2 (es)
DK (1) DK0470317T3 (es)
ES (1) ES2056415T3 (es)
FR (1) FR2665636B1 (es)
HK (1) HK56997A (es)
IE (1) IE65158B1 (es)
NZ (1) NZ235389A (es)
OA (1) OA09464A (es)
ZA (1) ZA907739B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
CA2093403C (en) * 1992-04-08 1999-08-10 Fumio Suzuki Therapeutic agent for parkinson's disease
FR2692784B1 (fr) * 1992-06-24 1995-06-30 Pf Medicament Utilisation de la guanosine, de ses precurseurs et ses derives pour la fabrication de medicaments destines a traiter les deficits fonctionnels cerebraux.
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
ATE325610T1 (de) * 1997-09-05 2006-06-15 Kyowa Hakko Kogyo Kk Xanthinderivative zur behandlung von hirnischämie
US6365593B2 (en) 2000-04-12 2002-04-02 Repligen Corporation Methylxanthines in the diagnosis and treatment of autistic disorder
AR039385A1 (es) * 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
SE0302756D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel Compounds
AU2004296137A1 (en) * 2003-12-09 2005-06-23 Kyowa Hakko Kirin Co., Ltd. Preventive and/or therapeutic agent for higher brain dysfunction
SE0402591D0 (sv) * 2004-10-25 2004-10-25 Astrazeneca Ab Novel use
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TW200804383A (en) * 2006-06-05 2008-01-16 Astrazeneca Ab New compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558162B1 (fr) * 1984-01-17 1986-04-25 Adir Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
GB8819494D0 (en) * 1988-08-16 1988-09-21 Ucb Sa Use of 2-amino-4-morpholino-6-propyl-1 3 5-triazines for preparation of psychotropic medicaments

Also Published As

Publication number Publication date
DE69008853D1 (de) 1994-06-16
FR2665636A1 (fr) 1992-02-14
OA09464A (fr) 1992-11-15
AU6322890A (en) 1992-05-14
CA2026118A1 (fr) 1992-02-11
AU631679B2 (en) 1992-12-03
US5173491A (en) 1992-12-22
ZA907739B (en) 1991-07-31
HK56997A (en) 1997-05-09
IE65158B1 (en) 1995-10-04
EP0470317A1 (fr) 1992-02-12
DE69008853T2 (de) 1994-10-13
ATE105478T1 (de) 1994-05-15
JPH0647539B2 (ja) 1994-06-22
DK0470317T3 (da) 1994-09-19
JPH0495029A (ja) 1992-03-27
CA2026118C (fr) 1998-07-14
EP0470317B1 (fr) 1994-05-11
FR2665636B1 (fr) 1994-10-07
NZ235389A (en) 1991-12-23

Similar Documents

Publication Publication Date Title
ES2056415T3 (es) Utilizacion de un derivado de la trimetil-1,3,7 xantina para la obtencion de medicamentos destinados al tratamiento de los trastornos de la memoria y de la enfermedad de alzheimer.
NL970006I1 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
FR2627696B1 (fr) Nouvelle forme galenique du fenofibrate
PT730864E (pt) Medicamento para tratar doencas inflamatorias cardiacas
DK0509317T3 (da) Lægemidler imod knoglesygdomme
FI941245A (fi) Menetelmä 2'-deoksiguanosiinin asyylijohdannaisten valmistamiseksi
PT99794A (pt) Processo para a preparacao de novas piperazinas 1,4-dissubstituidas
ATE154880T1 (de) Multifunktionelle pharmazeutische verbindungen und verfahren zu ihrer verwendung
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
DK122391A (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
DK112287A (da) Anvendelse af 2-alkoxy-n-(1-azabicyclo-oe2,2,2aaoct-3-yl)-benzamider og -thiobenzamider samt farmaceutisk acceptable syreadditionssalte deraf som laegemidler
DE59006868D1 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel.
ES2045945T3 (es) Forma de dosificacion para suministrar farmacos solubles o insolubles.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
DE3867042D1 (de) Pharmazeutische praeparate.
ES2096203T3 (es) Nuevos derivados de fisostigmina, su uso y formulaciones farmaceuticas que los contienen.
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
IT8722772A0 (it) Protesi ortopedica, particolarmente per la testa del femore.
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
DK0642338T3 (da) Anvendelse af (E)-2-(p-fluorphenethyl)-3-fluorallylamin i behandlingen af Alzheimers sygdom
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
SE8702227D0 (sv) New use
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
FI890173A (fi) Isoxazoler med nootropisk verkan.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 470317

Country of ref document: ES